adalimumab

:  an immunosuppressive drug that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis) ◆Adalimumab acts by binding to and blocking the activity of tumor necrosis factor. It is marketed under the trademark Humira. The labeling of adalimumab includes a boxed warning—the strongest type of label warning …—ACP Medicine, May 2007